Therefore, when comparing patients with psoriasis (n = 15) and healthy controls (n = 20), we measured the amount of IL-17A in the supernatant of each culture and subsequently used it to normalize CYP1A1 activity. The gene discussed is IL17A; the disease is psoriasis.